New Telemedicine Program Brings Top-Notch Cancer Care to More Marylanders
Telemedicine session at UMGCC
With the help of a new University of Maryland Greenebaum Cancer Center (UMGCC) telemedicine program, patients receiving cancer treatment at affiliated
community hospitals now have access to the same clinical trials and novel treatments
that are currently available at major academic cancer centers, such as UMGCC.
Patients can remain in their communities, but still receive the benefits of
"The great benefit for patients is that they can get access to the cutting
edge clinical trial opportunities and novel therapies that historically have
only existed at major academic institutions. Now they can get that care in their
own backyards," said William Regine, M.D., chairman of UMGCC's Department
of Radiation Oncology. Dr. Regine is also a professor of radiation oncology
at the University of Maryland School of Medicine.
Telemedicine, where physicians at different physical locations communicate
with each other in real time through video and telephone connections, allows
physicians at UMGCC's Department of Radiation Oncology in downtown Baltimore
to consult and review cases with physicians in affiliated radiation oncology
community practices in Anne Arundel and Howard Counties and together
decide the best treatment plan for patients and monitor patients' progress.
Patients treated at affiliated community radiation oncology centers have increased
opportunities to benefit from all that UMGCC has to offer.
Telemedicine is achieved using video cameras, television monitors and audio
connections to the other institutions through dedicated, high-speed telephone
lines. Doctors in Baltimore and the affiliated practices can evaluate patient's
films, their X-rays and other materials together at the same time.
"If they have a video image of the patient they want to show us, we can
literally see it here in Baltimore and discuss it live with our colleagues in
their community locations," said Mohan Suntha, M.D., vice chairman of the
Department of Radiation Oncology. Dr. Suntha is also a professor
of radiation oncology at the University of Maryland School of Medicine and associate director of the Greenebaum Cancer Center.
Doctors at the community practices
can present cases to UMGCC physicians and UMGCC physicians can present
cases to community physicians. The program allows physicians in all
practice areas to remain current on new therapies and approaches to treatment.
Should a patient need to come to UMGCC for treatment, physicians in Baltimore
will already be familiar with that patient's needs and will maintain ongoing
communication with referring physicians, returning patients to their local physicians
for follow-up care as soon as possible.
"Because this approach increases awareness and communication, we are convinced
that means better treatment options and patient care for patients downtown and
in the community," said Dr. Suntha. "In addition, telemedicine increases
the information that's passed from physician to physician about opportunities
for patients to enroll in clinical trials. Clinical trials give our patients the
option to consider new techniques that will not be commercially available for
up to five years. That's a huge step forward."
In the last several years, UMGCC has set up radiation oncology community practices
at Central Maryland Radiation Oncology in Howard County, and at Baltimore
Washington Medical Center's Tate Cancer Center.
The medical directors at these
centers are faculty members at the University of Maryland School
of Medicine and many of the faculty and staff are University employees.
The practices were set
up with a high level of technology, often only found at large academic
cancer centers. But as Dr. Suntha noted, one of the challenges with
high technology centers is how to keep all the centers talking to each
"When a patient walks in the door at CMRO or at Baltimore
Washington Medical Center, we are committed to ensuring that patients get the
same access to clinical trials that they would if they came to UMGCC in Baltimore.
UMGCC's telemedicine program provides the solution," he noted.
"What telemedicine has clearly allowed us to do is to integrate those
community programs under the umbrella of UMGCC and our overall cancer vision
to provide the best cancer care for Marylanders," Dr. Suntha said.
The telemedicine program
is funded through the Maryland Cigarette Restitution Fund Program (CRFP).
Within the CRFP, a portion of those funds went to the Maryland Statewide
Health Network (MSHN), developed and operated by the University of Maryland
School of Medicine. MSHN provided support for establishing the telemedicine
program at UMGCC to set up a teleconferencing network so that patients
in selected regions of the state could have access to the expertise,
clinical trials and novel therapies that have previously only been available
in Baltimore. Working with MSHN, UMGCC would like to extend this program
to other regions of the state.
Benefit to Patients and Doctors
Dr. Suntha cites the University of Maryland Medical Center's GammaKnife Center as a great example of how patients can benefit from this program.
"Since our morning conference in Baltimore now includes the participation
of our affiliated practices through the telemedicine link, we now hear about
patients who are seen in the community. We can make recommendations about Gamma
Knife therapy, which is a highly specialized treatment for brain tumors. Those
patients can come to UMGCC and be evaluated for that therapy. It is access to
technology like this that telemedicine allows us to emphasize."
In fact, he says the very first
day the program got started, there was a patient from one of the community
practices who had a brain tumor.
"The recommendation of using Gamma Knife technology on that patient and
combining it with external beam radiation in the community probably tripled
that patient's chance of being cured," stated Dr. Suntha. "So the
patient received Gamma Knife here at UMGCC and went back to our affiliated community
practice to receive his radiation therapy."
The Future of Telemedicine
"Telemedicine is in its infancy here at UMGCC, but we intend to expand
beyond just radiation oncology to really have multidisciplinary clinics and
conferences so that the community physician can actually access expertise from
a number of specialists all at once," said Dr. Suntha.
At these multidisciplinary
conferences, experts in surgery, medical oncology and radiation oncology
would meet together to discuss specific diseases (for example, lung
cancer) and teleconference to other locations so that community-based
physicians could access the expertise of all the UMGCC specialists at
the same time.
The missing link to realizing the benefits of the academic environment in non-academic
settings was real-time connectivity. This connectivity now exists among colleagues
associated with UMGCC throughout the region. "It's really the future of
where we want to take multidisciplinary care. Right now it works in its infancy
around radiation oncology. Our vision is to expand it across the cancer center
through all the specialties and remove all of the barriers to the academic village,"
said Dr. Suntha.